Terms: = Bone cancer AND CEACAM5, CEA AND Staging
27 results:
1. Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal cancer (PerSeUS-RC01).
Matsuhashi N; Takahashi T; Tanaka C; Yawata K; Yamada M; Iwata Y; Kiyama S; Mizutani C; Tajima JY; Ishihara T; Yoshida K
Anticancer Res; 2021 Dec; 41(12):6247-6257. PubMed ID: 34848480
[TBL] [Abstract] [Full Text] [Related]
2. Expressiveness of bone Markers in Breast cancer with bone Metastases.
Zulauf N; Brüggmann D; Groneberg D; Oremek GM
Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
[TBL] [Abstract] [Full Text] [Related]
3. Expression and clinical significance of serum NT5E protein in patients with colorectal cancer.
Wang G; Fu S; Li D; Chen Y
Cancer Biomark; 2019; 24(4):461-468. PubMed ID: 30932882
[TBL] [Abstract] [Full Text] [Related]
4. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Stewart CL; Warner S; Ito K; Raoof M; Wu GX; Kessler J; Kim JY; Fong Y
Curr Probl Surg; 2018 Sep; 55(9):330-379. PubMed ID: 30526930
[TBL] [Abstract] [Full Text] [Related]
5. Sclerosing odontogenic carcinoma presenting on the hard palate of a 43-year-old female: a case report.
Wood A; Young F; Morrison J; Conn BI
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e204-e208. PubMed ID: 27743835
[TBL] [Abstract] [Full Text] [Related]
6. A Simple Scoring System Predicting the Survival Time of Patients with bone Metastases after RT.
Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
[TBL] [Abstract] [Full Text] [Related]
7. Is there any correlation between levels of serum ostepontin, cea, and FDG uptake in lung cancer patients with bone metastasis?
Ayan AK; Erdemci B; Orsal E; Bayraktutan Z; Akpinar E; Topcu A; Turkeli M; Seven B
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):102-6. PubMed ID: 26521996
[TBL] [Abstract] [Full Text] [Related]
8. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract] [Full Text] [Related]
9. Lymph node cea and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
[TBL] [Abstract] [Full Text] [Related]
10. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract] [Full Text] [Related]
11. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.
Wakabayashi H; Nishiyama Y; Otani T; Sano T; Yachida S; Okano K; Izuishi K; Suzuki Y
World J Gastroenterol; 2008 Jan; 14(1):64-9. PubMed ID: 18176963
[TBL] [Abstract] [Full Text] [Related]
12. Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A; Salaun PY; Bournaud C; Campion L; Ansquer C; Rousseau C; Bardet S; Borson-Chazot F; Vuillez JP; Murat A; Mirallié E; Barbet J; Goldenberg DM; Chatal JF; Kraeber-Bodéré F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4590-7. PubMed ID: 17878252
[TBL] [Abstract] [Full Text] [Related]
13. bone marrow and sentinel lymph node biopsy in patients with breast cancer: from staging to ultrastaging?
Fortunato L; Baldi A; Farina M; Campioni M; Amini M; Piro FR; Costarelli L; Pompili P; Vitelli CE
J Exp Clin Cancer Res; 2006 Dec; 25(4):487-93. PubMed ID: 17310838
[TBL] [Abstract] [Full Text] [Related]
14. [CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance].
Na GW; Li J; He KJ; Li HH; Zhao XN; Li XW; Mi HN
Ai Zheng; 2004 Nov; 23(11):1350-3. PubMed ID: 15522189
[TBL] [Abstract] [Full Text] [Related]
15. staging of breast cancer: new recommended standard procedure.
Ravaioli A; Pasini G; Polselli A; Papi M; Tassinari D; Arcangeli V; Milandri C; Amadori D; Bravi M; Rossi D; Fattori PP; Pasquini E; Panzini I
Breast Cancer Res Treat; 2002 Mar; 72(1):53-60. PubMed ID: 12000220
[TBL] [Abstract] [Full Text] [Related]
16. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
Nicolini A; Ferrari P; Sagripanti A; Carpi A
Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
[TBL] [Abstract] [Full Text] [Related]
17. [Considerations in rational use of tumor markers in breast carcinoma].
Crombach G
Praxis (Bern 1994); 1998 Apr; 87(17):589-94. PubMed ID: 9623326
[TBL] [Abstract] [Full Text] [Related]
18. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM
J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376
[TBL] [Abstract] [Full Text] [Related]
19. [Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].
Broll R; Lembcke K; Stock C; Zingler M; Duchrow M; Schimmelpenning H; Strik M; Muller G; Kujath P; Bruch HP
Langenbecks Arch Chir; 1996; 381(1):51-8. PubMed ID: 8717176
[TBL] [Abstract] [Full Text] [Related]
20. [Monoclonal antibodies and bronchial cancer].
Charloux A; Kreisman H; Quoix E; Pauli G
Bull Cancer; 1994 Sep; 81(9):755-63. PubMed ID: 7703564
[TBL] [Abstract] [Full Text] [Related]
[Next]
